Literature DB >> 25729117

A Simple Method for Estimating Interactions between a Treatment and a Large Number of Covariates.

Lu Tian1, Ash A Alizadeh2, Andrew J Gentles3, Robert Tibshirani4.   

Abstract

We consider a setting in which we have a treatment and a potentially large number of covariates for a set of observations, and wish to model their relationship with an outcome of interest. We propose a simple method for modeling interactions between the treatment and covariates. The idea is to modify the covariate in a simple way, and then fit a standard model using the modified covariates and no main effects. We show that coupled with an efficiency augmentation procedure, this method produces clinically meaningful estimators in a variety of settings. It can be useful for practicing personalized medicine: determining from a large set of biomarkers the subset of patients that can potentially benefit from a treatment. We apply the method to both simulated datasets and real trial data. The modified covariates idea can be used for other purposes, for example, large scale hypothesis testing for determining which of a set of covariates interact with a treatment variable.

Entities:  

Year:  2014        PMID: 25729117      PMCID: PMC4338439          DOI: 10.1080/01621459.2014.951443

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  14 in total

1.  Adaptive index models for marker-based risk stratification.

Authors:  Lu Tian; Robert Tibshirani
Journal:  Biostatistics       Date:  2010-07-27       Impact factor: 5.899

2.  Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

Authors:  Scott D Solomon; Madeline M Rice; Kathleen A Jablonski; Powell Jose; Michael Domanski; Marc Sabatine; Bernard J Gersh; Jean Rouleau; Marc A Pfeffer; Eugene Braunwald
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

3.  On Bayesian methods of exploring qualitative interactions for targeted treatment.

Authors:  Wei Chen; Debashis Ghosh; Trivellore E Raghunathan; Maxim Norkin; Daniel J Sargent; Gerold Bepler
Journal:  Stat Med       Date:  2012-06-26       Impact factor: 2.373

4.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

5.  Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.

Authors:  Sherene Loi; Benjamin Haibe-Kains; Christine Desmedt; Françoise Lallemand; Andrew M Tutt; Cheryl Gillet; Paul Ellis; Adrian Harris; Jonas Bergh; John A Foekens; Jan G M Klijn; Denis Larsimont; Marc Buyse; Gianluca Bontempi; Mauro Delorenzi; Martine J Piccart; Christos Sotiriou
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

6.  Diagnosis of multiple cancer types by shrunken centroids of gene expression.

Authors:  Robert Tibshirani; Trevor Hastie; Balasubramanian Narasimhan; Gilbert Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

7.  Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

Authors:  Eugene Braunwald; Michael J Domanski; Sarah E Fowler; Nancy L Geller; Bernard J Gersh; Judith Hsia; Marc A Pfeffer; Madeline M Rice; Yves D Rosenberg; Jean L Rouleau
Journal:  N Engl J Med       Date:  2004-11-07       Impact factor: 91.245

8.  Patterns of treatment effects in subsets of patients in clinical trials.

Authors:  Marco Bonetti; Richard D Gelber
Journal:  Biostatistics       Date:  2004-07       Impact factor: 5.899

9.  Non-Asymptotic Oracle Inequalities for the High-Dimensional Cox Regression via Lasso.

Authors:  Shengchun Kong; Bin Nan
Journal:  Stat Sin       Date:  2014-01-01       Impact factor: 1.261

10.  ORACLE INEQUALITIES FOR THE LASSO IN THE COX MODEL.

Authors:  Jian Huang; Tingni Sun; Zhiliang Ying; Yi Yu; Cun-Hui Zhang
Journal:  Ann Stat       Date:  2013-06-01       Impact factor: 4.028

View more
  56 in total

1.  Patient subgroup identification for clinical drug development.

Authors:  Xin Huang; Yan Sun; Paul Trow; Saptarshi Chatterjee; Arunava Chakravartty; Lu Tian; Viswanath Devanarayan
Journal:  Stat Med       Date:  2017-02-01       Impact factor: 2.373

2.  DOUBLY ROBUST ESTIMATION OF OPTIMAL TREATMENT REGIMES FOR SURVIVAL DATA-WITH APPLICATION TO AN HIV/AIDS STUDY.

Authors:  Runchao Jiang; Wenbin Lu; Rui Song; Michael G Hudgens; Sonia Naprvavnik
Journal:  Ann Appl Stat       Date:  2017-10-05       Impact factor: 2.083

3.  Recursive partitioning for heterogeneous causal effects.

Authors:  Susan Athey; Guido Imbens
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

4.  Flexible functional regression methods for estimating individualized treatment regimes.

Authors:  Adam Ciarleglio; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  Stat (Int Stat Inst)       Date:  2016-05-31

5.  A general statistical framework for subgroup identification and comparative treatment scoring.

Authors:  Shuai Chen; Lu Tian; Tianxi Cai; Menggang Yu
Journal:  Biometrics       Date:  2017-02-17       Impact factor: 2.571

6.  Look before you leap: systematic evaluation of tree-based statistical methods in subgroup identification.

Authors:  Yang Liu; Xiwen Ma; Donghui Zhang; Lijiang Geng; Xiaojing Wang; Wei Zheng; Ming-Hui Chen
Journal:  J Biopharm Stat       Date:  2019-03-12       Impact factor: 1.051

7.  High-Dimensional Inference for Personalized Treatment Decision.

Authors:  X Jessie Jeng; Wenbin Lu; Huimin Peng
Journal:  Electron J Stat       Date:  2018-06-21       Impact factor: 1.125

8.  Greedy outcome weighted tree learning of optimal personalized treatment rules.

Authors:  Ruoqing Zhu; Ying-Qi Zhao; Guanhua Chen; Shuangge Ma; Hongyu Zhao
Journal:  Biometrics       Date:  2016-10-04       Impact factor: 2.571

9.  A single-index model with multiple-links.

Authors:  Hyung Park; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  J Stat Plan Inference       Date:  2019-07-04       Impact factor: 1.111

10.  Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.

Authors:  R Jeffrey Karnes; Vidit Sharma; Voleak Choeurng; Hussam Al-Deen Ashab; Nicholas Erho; Mohammed Alshalalfa; Bruce Trock; Ashley Ross; Kasra Yousefi; Harrison Tsai; Shuang G Zhao; Jeffrey J Tosoian; Zaid Haddad; Mandeep Takhar; S Laura Chang; Daniel E Spratt; Firas Abdollah; Robert B Jenkins; Eric A Klein; Paul L Nguyen; Adam P Dicker; Robert B Den; Elai Davicioni; Felix Y Feng; Tamara L Lotan; Edward M Schaeffer
Journal:  Clin Cancer Res       Date:  2018-05-14       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.